# ARBLI
> **NDA218772** · New Drug Application · Sponsor: SCIENTURE · Approved 2025-03-13
## Drug
- **FDA Application Number:** NDA218772
- **Application type:** New Drug Application
- **Brand name:** ARBLI
- **Generic name:** LOSARTAN POTASSIUM
- **Active ingredients:** LOSARTAN POTASSIUM
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIENTURE
- **Manufacturer:** Scienture LLC
- **First approval:** 2025-03-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218772)
---
*AI Analytics · CC0 1.0*